Cargando…
High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesve...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388240/ https://www.ncbi.nlm.nih.gov/pubmed/28435280 http://dx.doi.org/10.2147/VHRM.S119490 |
_version_ | 1782521095808614400 |
---|---|
author | Goss, Franz Brachmann, Johannes Hamm, Christian W Haerer, Winfried Reifart, Nicolaus Levenson, Benny |
author_facet | Goss, Franz Brachmann, Johannes Hamm, Christian W Haerer, Winfried Reifart, Nicolaus Levenson, Benny |
author_sort | Goss, Franz |
collection | PubMed |
description | We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesverband Niedergelassener Kardiologen [German Federation of Office-Based Cardiologists] cardiac pass with visit scheduling) shared by the hospital physician and the office-based cardiologist, the definition of individual treatment targets, and the systematic information of patients in order to optimize adherence to therapy. Participating centers (36 hospitals, 60 office-based cardiologists) included a total of 1,003 patients with ACS (ST-segment elevation myocardial infarction [STEMI] 44.3%, non-ST-segment elevation myocardial infarction [NSTEMI] 39.5%, unstable angina pectoris [UA] 15.2%, and unspecified 1.0%). During follow-up, treatment rates with cardiac medication remained high in all groups, with dual antiplatelet therapy in 91.0% at 3 months, 90.0% at 6 months, and 82.8% at 12 months, respectively. Twelve months after the inclusion, a total of 798 patients (79.6%) still participated in the program. Eighteen patients (1.8%) had died after discharge from hospital (6 in the STEMI, 12 in the NSTEMI group), while for 58 the status was unknown (5.8%). Based on a conservative approach that considered patients with unknown status as dead, 1-year mortality was 7.6%. Recurrent cardiac events were noted in 14.9% at 1 year, with an about equal distribution across STEMI and NSTEMI patients. In conclusion, patients’ acceptance of the ProAcor program as determined by adherence rates over time was high. Treatment rates of recommended medications used for patients with coronary heart disease were excellent. The 1-year mortality rate was comparatively low. |
format | Online Article Text |
id | pubmed-5388240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53882402017-04-21 High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study Goss, Franz Brachmann, Johannes Hamm, Christian W Haerer, Winfried Reifart, Nicolaus Levenson, Benny Vasc Health Risk Manag Original Research We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesverband Niedergelassener Kardiologen [German Federation of Office-Based Cardiologists] cardiac pass with visit scheduling) shared by the hospital physician and the office-based cardiologist, the definition of individual treatment targets, and the systematic information of patients in order to optimize adherence to therapy. Participating centers (36 hospitals, 60 office-based cardiologists) included a total of 1,003 patients with ACS (ST-segment elevation myocardial infarction [STEMI] 44.3%, non-ST-segment elevation myocardial infarction [NSTEMI] 39.5%, unstable angina pectoris [UA] 15.2%, and unspecified 1.0%). During follow-up, treatment rates with cardiac medication remained high in all groups, with dual antiplatelet therapy in 91.0% at 3 months, 90.0% at 6 months, and 82.8% at 12 months, respectively. Twelve months after the inclusion, a total of 798 patients (79.6%) still participated in the program. Eighteen patients (1.8%) had died after discharge from hospital (6 in the STEMI, 12 in the NSTEMI group), while for 58 the status was unknown (5.8%). Based on a conservative approach that considered patients with unknown status as dead, 1-year mortality was 7.6%. Recurrent cardiac events were noted in 14.9% at 1 year, with an about equal distribution across STEMI and NSTEMI patients. In conclusion, patients’ acceptance of the ProAcor program as determined by adherence rates over time was high. Treatment rates of recommended medications used for patients with coronary heart disease were excellent. The 1-year mortality rate was comparatively low. Dove Medical Press 2017-04-06 /pmc/articles/PMC5388240/ /pubmed/28435280 http://dx.doi.org/10.2147/VHRM.S119490 Text en © 2017 Goss et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Goss, Franz Brachmann, Johannes Hamm, Christian W Haerer, Winfried Reifart, Nicolaus Levenson, Benny High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
title | High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
title_full | High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
title_fullStr | High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
title_full_unstemmed | High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
title_short | High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
title_sort | high adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in germany: 1-year outcomes of the proacor study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388240/ https://www.ncbi.nlm.nih.gov/pubmed/28435280 http://dx.doi.org/10.2147/VHRM.S119490 |
work_keys_str_mv | AT gossfranz highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy AT brachmannjohannes highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy AT hammchristianw highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy AT haererwinfried highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy AT reifartnicolaus highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy AT levensonbenny highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy |